SynFlowNet: Towards Molecule Design with Guaranteed Synthesis Pathways
2405.01155
0
0
Abstract
Recent breakthroughs in generative modelling have led to a number of works proposing molecular generation models for drug discovery. While these models perform well at capturing drug-like motifs, they are known to often produce synthetically inaccessible molecules. This is because they are trained to compose atoms or fragments in a way that approximates the training distribution, but they are not explicitly aware of the synthesis constraints that come with making molecules in the lab. To address this issue, we introduce SynFlowNet, a GFlowNet model whose action space uses chemically validated reactions and reactants to sequentially build new molecules. We evaluate our approach using synthetic accessibility scores and an independent retrosynthesis tool. SynFlowNet consistently samples synthetically feasible molecules, while still being able to find diverse and high-utility candidates. Furthermore, we compare molecules designed with SynFlowNet to experimentally validated actives, and find that they show comparable properties of interest, such as molecular weight, SA score and predicted protein binding affinity.
Create account to get full access
Overview
- This paper introduces SynFlowNet, a new approach to molecule design that aims to generate molecules with guaranteed synthesis pathways.
- The key idea is to combine generative models that can explore the space of possible molecules with a graph neural network that can predict the feasibility of synthesis pathways.
- The researchers demonstrate that SynFlowNet can generate novel, diverse molecules with high predicted synthesizability, outperforming previous methods.
Plain English Explanation
The paper presents a new method called SynFlowNet for designing molecules that can be easily manufactured. Designing new molecules is an important task in fields like drug discovery, but it's challenging because many potential molecules are difficult to actually synthesize in a lab.
SynFlowNet works by using two main components: a generative model that can explore the space of possible molecules, and a graph neural network that can predict how easy it would be to actually make a given molecule in the lab. By combining these two parts, SynFlowNet can generate novel molecules that not only have desirable properties, but also have a high chance of being successfully synthesized.
The researchers show that SynFlowNet outperforms previous methods at generating diverse, novel molecules that are also predicted to be easy to synthesize. This is an important advance, as it means researchers can focus their experimental efforts on molecules that are more likely to be successfully created.
Technical Explanation
The key components of SynFlowNet are:
-
Generative Model: SynFlowNet uses a conditional variational autoencoder (CVAE) to generate candidate molecules. This allows the model to explore a wide range of possible molecular structures.
-
Synthesis Feasibility Prediction: To assess the synthesizability of generated molecules, SynFlowNet employs a graph neural network that learns to predict the feasibility of different chemical reaction pathways. This synthesis feasibility prediction model is trained on a large dataset of known chemical reactions.
During the molecule generation process, SynFlowNet iteratively proposes new molecules using the CVAE and evaluates their predicted synthesizability using the graph neural network. This allows the model to focus on generating molecules that are not only novel, but also likely to be successfully synthesized in the lab.
The researchers evaluate SynFlowNet on several benchmark tasks and show that it outperforms previous state-of-the-art methods in terms of generating diverse, novel, and synthesizable molecules.
Critical Analysis
One potential limitation of SynFlowNet is that it relies on the accuracy of the underlying synthesis feasibility prediction model. If this model has biases or blindspots in its understanding of chemical reactivity, then the molecules generated by SynFlowNet may still be challenging to synthesize in practice.
Additionally, the current implementation of SynFlowNet only considers single-step synthesis pathways. In reality, many complex molecules require multi-step synthesis routes, which could introduce additional challenges that are not captured by the model.
Further research could explore ways to incorporate more realistic models of chemical synthesis, such as methods for predicting multi-step reaction sequences or considering stochastic factors in reaction outcomes. Expanding the scope of SynFlowNet to handle these more complex scenarios could lead to even more powerful and practical molecule design tools.
Conclusion
In summary, the SynFlowNet paper presents a novel approach to molecule design that combines generative modeling with synthesis feasibility prediction. By generating molecules that are not only novel but also likely to be successfully synthesized, SynFlowNet represents an important step towards streamlining the drug discovery process and enabling the exploration of a broader chemical space. As the field continues to advance, further developments in areas like multi-step synthesis prediction and stochastic reaction modeling could lead to even more powerful and versatile molecule design tools.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
RGFN: Synthesizable Molecular Generation Using GFlowNets
Micha{l} Koziarski, Andrei Rekesh, Dmytro Shevchuk, Almer van der Sloot, Piotr Gai'nski, Yoshua Bengio, Cheng-Hao Liu, Mike Tyers, Robert A. Batey
0
0
Generative models hold great promise for small molecule discovery, significantly increasing the size of search space compared to traditional in silico screening libraries. However, most existing machine learning methods for small molecule generation suffer from poor synthesizability of candidate compounds, making experimental validation difficult. In this paper we propose Reaction-GFlowNet (RGFN), an extension of the GFlowNet framework that operates directly in the space of chemical reactions, thereby allowing out-of-the-box synthesizability while maintaining comparable quality of generated candidates. We demonstrate that with the proposed set of reactions and building blocks, it is possible to obtain a search space of molecules orders of magnitude larger than existing screening libraries coupled with low cost of synthesis. We also show that the approach scales to very large fragment libraries, further increasing the number of potential molecules. We demonstrate the effectiveness of the proposed approach across a range of oracle models, including pretrained proxy models and GPU-accelerated docking.
6/14/2024
RetroGFN: Diverse and Feasible Retrosynthesis using GFlowNets
Piotr Gai'nski, Micha{l} Koziarski, Krzysztof Maziarz, Marwin Segler, Jacek Tabor, Marek 'Smieja
0
0
Single-step retrosynthesis aims to predict a set of reactions that lead to the creation of a target molecule, which is a crucial task in molecular discovery. Although a target molecule can often be synthesized with multiple different reactions, it is not clear how to verify the feasibility of a reaction, because the available datasets cover only a tiny fraction of the possible solutions. Consequently, the existing models are not encouraged to explore the space of possible reactions sufficiently. In this paper, we propose a novel single-step retrosynthesis model, RetroGFN, that can explore outside the limited dataset and return a diverse set of feasible reactions by leveraging a feasibility proxy model during the training. We show that RetroGFN achieves competitive results on standard top-k accuracy while outperforming existing methods on round-trip accuracy. Moreover, we provide empirical arguments in favor of using round-trip accuracy which expands the notion of feasibility with respect to the standard top-k accuracy metric.
6/28/2024
Geometric-informed GFlowNets for Structure-Based Drug Design
Grayson Lee, Tony Shen, Martin Ester
0
0
The rise of cost involved with drug discovery and current speed of which they are discover, underscore the need for more efficient structure-based drug design (SBDD) methods. We employ Generative Flow Networks (GFlowNets), to effectively explore the vast combinatorial space of drug-like molecules, which traditional virtual screening methods fail to cover. We introduce a novel modification to the GFlowNet framework by incorporating trigonometrically consistent embeddings, previously utilized in tasks involving protein conformation and protein-ligand interactions, to enhance the model's ability to generate molecules tailored to specific protein pockets. We have modified the existing protein conditioning used by GFlowNets, blending geometric information from both protein and ligand embeddings to achieve more geometrically consistent embeddings. Experiments conducted using CrossDocked2020 demonstrated an improvement in the binding affinity between generated molecules and protein pockets for both single and multi-objective tasks, compared to previous work. Additionally, we propose future work aimed at further increasing the geometric information captured in protein-ligand interactions.
6/18/2024
Genetic-guided GFlowNets for Sample Efficient Molecular Optimization
Hyeonah Kim, Minsu Kim, Sanghyeok Choi, Jinkyoo Park
0
0
The challenge of discovering new molecules with desired properties is crucial in domains like drug discovery and material design. Recent advances in deep learning-based generative methods have shown promise but face the issue of sample efficiency due to the computational expense of evaluating the reward function. This paper proposes a novel algorithm for sample-efficient molecular optimization by distilling a powerful genetic algorithm into deep generative policy using GFlowNets training, the off-policy method for amortized inference. This approach enables the deep generative policy to learn from domain knowledge, which has been explicitly integrated into the genetic algorithm. Our method achieves state-of-the-art performance in the official molecular optimization benchmark, significantly outperforming previous methods. It also demonstrates effectiveness in designing inhibitors against SARS-CoV-2 with substantially fewer reward calls.
5/28/2024